Literature DB >> 18234888

Netrin-1 is a novel myelin-associated inhibitor to axon growth.

Karin Löw1, Maya Culbertson, Frank Bradke, Marc Tessier-Lavigne, Mark H Tuszynski.   

Abstract

We investigated the influence of the bifunctional guidance molecule netrin-1 on axonal growth in the injured adult spinal cord. In the adult, netrin-1 is expressed on mature oligodendrocytes, cells of the central canal, and the meninges. Netrin-1 protein in white matter is selectively enriched adjacent to paranodal loops of myelin in nodes of Ranvier. The repulsion-mediating netrin-1 uncoordinated-5 (UNC5) receptors are expressed by neurons of the corticospinal and rubrospinal projections, and by intrinsic neurons of the spinal cord, both before and after spinal cord injury. Neutralization of netrin-1 in myelin prepared from adult rat spinal cord using UNC5 receptor bodies increases neurite outgrowth from UNC5-expressing spinal motor neurons in vitro. Furthermore, axon regeneration is inhibited in a netrin-1-enriched zone, devoid of other myelin-associated inhibitors, within spinal cord lesion sites in vivo. We conclude that netrin-1 is a novel oligodendrocyte-associated inhibitor that can contribute to axonal growth failure after adult spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234888      PMCID: PMC6671394          DOI: 10.1523/JNEUROSCI.4906-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury.

Authors:  Philip Duffy; Xingxing Wang; Chad S Siegel; Chad S Seigel; Nathan Tu; Mark Henkemeyer; William B J Cafferty; Stephen M Strittmatter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

Review 2.  C. elegans as a genetic model to identify novel cellular and molecular mechanisms underlying nervous system regeneration.

Authors:  Hui Chiu; Amel Alqadah; Chiou-Fen Chuang; Chieh Chang
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

3.  Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.

Authors:  Xingxing Wang; Omar Hasan; Alexander Arzeno; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Exp Neurol       Date:  2012-06-21       Impact factor: 5.330

Review 4.  Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.

Authors:  Erna A van Niekerk; Mark H Tuszynski; Paul Lu; Jennifer N Dulin
Journal:  Mol Cell Proteomics       Date:  2015-12-22       Impact factor: 5.911

Review 5.  Axon Guidance Molecules and Neural Circuit Remodeling After Spinal Cord Injury.

Authors:  Edmund R Hollis
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 6.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

Review 7.  Targets for neural repair therapies after stroke.

Authors:  S Thomas Carmichael
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

8.  Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord.

Authors:  Philip Duffy; Andre Schmandke; Antonio Schmandke; Jonathan Sigworth; Shuh Narumiya; William B J Cafferty; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

Review 9.  Axon regeneration in C. elegans: Worming our way to mechanisms of axon regeneration.

Authors:  Alexandra B Byrne; Marc Hammarlund
Journal:  Exp Neurol       Date:  2016-08-26       Impact factor: 5.330

10.  Reinduced Wnt signaling limits regenerative potential of sensory axons in the spinal cord following conditioning lesion.

Authors:  Edmund R Hollis; Yimin Zou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.